Marjolein H.
- Country
- The Netherlands
- Department
- Internal medicine
Research Overview
- European Randomised Clinical Trial on mPOX Infection (EPOXI)
- Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of VE303 for Recurrent Clostridioides difficile Infection Prevention in Adults
- Evaluation of Cefazolin Sodium, Flucloxacillin Sodium Monohydrate, and Clindamycin in Reducing Antibiotic Duration for Complicated Staphylococcus aureus Bacteremia
Data & Insights
Has run more than one trial at 10 of 152 partner sites.
Specializations
Infectious Disease Management
This investigator specializes in the treatment and prevention of serious bacterial and viral infections, with particular emphasis on Staphylococcus aureus bacteremia and emerging infectious diseases like monkeypox.
- Bacteremia Treatment Optimization
- Antibiotic Duration Protocols
- Viral Disease Management
Their work encompasses innovative approaches to treatment duration and therapeutic interventions for complex bacterial infections.
Bacterial Infections
The investigator focuses on managing complex bacterial conditions, particularly Clostridioides difficile infections and their recurrence prevention strategies.
- Recurrent Infection Prevention
- Novel Therapeutic Approaches
- Treatment Response Assessment
Their research addresses critical aspects of bacterial infection management and prevention protocols.
Clinical Outcomes
The investigator evaluates therapeutic interventions focusing on mortality reduction and infection resolution in serious infectious conditions.
- Treatment Efficacy Assessment
- Patient Response Monitoring
- Clinical Resolution Metrics
Their work encompasses comprehensive evaluation of treatment outcomes in severe infections.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.